PLATINUM-RESISTANT HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER
Clinical trials for PLATINUM-RESISTANT HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new PLATINUM-RESISTANT HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER trials appear
Sign up with your email to follow new studies for PLATINUM-RESISTANT HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for Platinum-Resistant ovarian cancer: new pill takes on chemo
Disease control Recruiting nowThis Phase 3 trial tests a new oral drug, INCB123667, against standard chemotherapy in 466 people with platinum-resistant ovarian cancer that overexpresses cyclin E1. The goal is to see if the new drug can delay cancer growth or improve survival. Participants will be randomly ass…
Matched conditions: PLATINUM-RESISTANT HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for Platinum-Resistant ovarian cancer?
Disease control Recruiting nowThis early-stage trial tests an investigational drug called ABBV-901, alone or with a standard drug bevacizumab, in about 219 adults with advanced ovarian cancer that no longer responds to platinum chemotherapy. The main goals are to check safety and see if the drug can shrink tu…
Matched conditions: PLATINUM-RESISTANT HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC